News on Santarus from BioPortfolio.com http://www.BioPortfolio.com Consolidated Santarus news from BioPortfolio.com Wed, 10 Feb 2010 08:29:32 GMT en Depomed to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010078&HITNO=0&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010078&THISHREF=http://c.moreover.com/click/here.pl%3fz2522226543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010078&HITNO=0&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010078&THISHREF=http://c.moreover.com/click/here.pl%3fz2522226543%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Depomed to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999308&HITNO=1&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999308&THISHREF=http://c.moreover.com/click/here.pl%3fz2517409069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999308&HITNO=1&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999308&THISHREF=http://c.moreover.com/click/here.pl%3fz2517409069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Depomed to Present at the 12th Annual BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998254&HITNO=2&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998254&THISHREF=http://c.moreover.com/click/here.pl%3fz2517013325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998254&HITNO=2&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998254&THISHREF=http://c.moreover.com/click/here.pl%3fz2517013325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Santarus Submits IND for Phase III Clinical Testing of Rifamycin SV MMX in Travelers' Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888089&HITNO=3&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888089&THISHREF=http://c.moreover.com/click/here.pl%3fz2458302782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3888089&HITNO=3&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3888089&THISHREF=http://c.moreover.com/click/here.pl%3fz2458302782%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: 1/10/10 - Santarus Receives Previously Announced $20 Million Milestone for FDA Approval of ZEGERID OTChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883502&HITNO=4&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883502&THISHREF=http://c.moreover.com/click/here.pl%3fz2455780573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3883502&HITNO=4&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3883502&THISHREF=http://c.moreover.com/click/here.pl%3fz2455780573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Santarus Submits IND for Phase III Clinical Testing of Rifamycin SV MMX in Travelers' Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861613&HITNO=5&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861613&THISHREF=http://c.moreover.com/click/here.pl%3fz2444528767%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3861613&HITNO=5&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3861613&THISHREF=http://c.moreover.com/click/here.pl%3fz2444528767%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Santarus seeks US FDA nod to begin phase III trial of rifamycin SV MMX in travellers' diarrhoeahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3850255&HITNO=6&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3850255&THISHREF=http://c.moreover.com/click/here.pl%3fz2439743271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3850255&HITNO=6&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3850255&THISHREF=http://c.moreover.com/click/here.pl%3fz2439743271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Santarus Submits IND For Phase III Clinical Testing Of Rifamycin SV MMX In Travelers' Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848699&HITNO=7&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848699&THISHREF=http://c.moreover.com/click/here.pl%3fz2437585044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848699&HITNO=7&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848699&THISHREF=http://c.moreover.com/click/here.pl%3fz2437585044%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Santarus Submits IND For Phase III Clinical Testing Of Rifamycin SV MMX In Travelers' Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848615&HITNO=8&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848615&THISHREF=http://c.moreover.com/click/here.pl%3fz2437505019%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848615&HITNO=8&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848615&THISHREF=http://c.moreover.com/click/here.pl%3fz2437505019%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: Medical News: Santarus Submits IND For Phase III Clinical Testing Of Rifamycin SV MMX In Travelers' Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848764&HITNO=9&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848764&THISHREF=http://c.moreover.com/click/here.pl%3fz2437644613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848764&HITNO=9&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848764&THISHREF=http://c.moreover.com/click/here.pl%3fz2437644613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: BiomedReports: News and FDA Updates for Origin Agritech (NASDAQ:SEED), Rite Aid (NYSE:RAD), Santarus (NASDAQ:Shttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3849187&HITNO=10&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3849187&THISHREF=http://c.moreover.com/click/here.pl%3fz2438164367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3849187&HITNO=10&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3849187&THISHREF=http://c.moreover.com/click/here.pl%3fz2438164367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Santarus Receives Previously Announced $20 Million Milestone for FDA Approval of ZEGERID OTChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848107&HITNO=11&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848107&THISHREF=http://c.moreover.com/click/here.pl%3fz2436838587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848107&HITNO=11&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848107&THISHREF=http://c.moreover.com/click/here.pl%3fz2436838587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Santarus Submits IND for Phase III Testing of Rifamycin in Travelers Diarrheahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848297&HITNO=12&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848297&THISHREF=http://c.moreover.com/click/here.pl%3fz2437060082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3848297&HITNO=12&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3848297&THISHREF=http://c.moreover.com/click/here.pl%3fz2437060082%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFDA News: Santarus gets US$ 20 mn milestone payment for Zegerid OTC from Schering-Ploughhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3828147&HITNO=13&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3828147&THISHREF=http://c.moreover.com/click/here.pl%3fz2422791010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3828147&HITNO=13&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3828147&THISHREF=http://c.moreover.com/click/here.pl%3fz2422791010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Santarus Receives Previously Announced $20 Million Milestone for FDA Approval of ZEGERID OTChttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3817824&HITNO=14&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3817824&THISHREF=http://c.moreover.com/click/here.pl%3fz2418248358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3817824&HITNO=14&MSIZE=25&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Santarus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3817824&THISHREF=http://c.moreover.com/click/here.pl%3fz2418248358%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: